NEUROENDOCRINE RESPONSES TO D-FENFLURAMINE AND INSULIN-INDUCED HYPOGLYCEMIA IN CHRONIC FATIGUE SYNDROME

被引:80
作者
BEARN, J
ALLAIN, T
COSKERAN, P
MUNRO, N
BUTLER, J
MCGREGOR, A
WESSELY, S
机构
[1] INST PSYCHIAT, DEPT PSYCHIAT, LONDON SE5 8AF, ENGLAND
[2] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT MED, LONDON WC2R 2LS, ENGLAND
[3] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT PSYCHOL MED, LONDON WC2R 2LS, ENGLAND
[4] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT CLIN BIOCHEM, LONDON WC2R 2LS, ENGLAND
[5] MIDDLESEX HOSP, DEPT NEUROL, LONDON W1N 8AA, ENGLAND
基金
英国惠康基金; 英国医学研究理事会;
关键词
CHRONIC FATIGUE SYNDROME; CORTISOL; GROWTH HORMONE; PROLACTIN; D-FENFLURAMINE; HYPOGLYCEMIA;
D O I
10.1016/0006-3223(94)00121-I
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic fatigue syndrome (CFS) is a disorder characterized by severe physical and mental fatigue and fatiguability of central rather than peripheral origin. We hypothesized that CFS is mediated by changes in hypothalamopituitary function and so measured the adrenocorticotrophic hormone (ACTH), cortisol, growth hormone, and prolactin responses to insulin-induced hypoglycemia, and the ACTH, cortisol, and prolactin responses to serotoninergic stimulation with dexfenfluramine in nondepressed CFS patients and normal controls. We have shown attenuated prolactin responses to hypoglycemia in CFS. There was also a greater ACTH response and higher peak ACTH concentrations (36.44 +/- 4.45 versus 25.60 +/- 2.78 pg ml), whereas cortisol responses did not differ, findings that are compatible with impaired adrenal cortical function. This study provided evidence for both pituitary and adrenal cortical impairment in CFS and further studies are merited to both confirm and determine more precisely their neurobiological basis so that rational treatments can be evolved.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 32 条
[21]  
MELTZER HY, 1992, ARCH GEN PSYCHIAT, V49, P163
[22]   COMPARISON OF ADRENAL RESPONSES TO HYPOGLYCEMIA, METYRAPONE AND ACTH [J].
NELSON, JC ;
TINDALL, DJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1978, 275 (02) :165-172
[23]  
OKEANE V, 1991, AM J PSYCHIAT, V148, P1009
[24]  
OSTERMAN PO, 1976, ACTA ENDOCRINOL-COP, V83, P341, DOI 10.1530/acta.0.0830341
[25]   SELECTIVE INTERACTION OF NOVEL ANXIOLYTICS WITH 5-HYDROXYTRYPTAMINE1A RECEPTORS [J].
PEROUTKA, SJ .
BIOLOGICAL PSYCHIATRY, 1985, 20 (09) :971-979
[26]  
RURTHERFORD O, 1991, J NEUROL NEUROSUR PS, V54, P961
[27]  
SACHAR EJ, 1971, ARCH GEN PSYCHIAT, V25, P263
[28]   CHRONIC FATIGUE SYNDROME RESEARCH - DEFINITION AND MEDICAL OUTCOME ASSESSMENT [J].
SCHLUEDERBERG, A ;
STRAUS, SE ;
PETERSON, P ;
BLUMENTHAL, S ;
KOMAROFF, AL ;
SPRING, SB ;
LANDAY, A ;
BUCHWALD, D .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) :325-331
[29]   A REPORT-CHRONIC FATIGUE SYNDROME - GUIDELINES FOR RESEARCH [J].
SHARPE, MC .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (02) :118-121
[30]   FATIGUE SYNDROMES - A COMPARISON OF CHRONIC POSTVIRAL FATIGUE WITH NEUROMUSCULAR AND AFFECTIVE-DISORDERS [J].
WESSELY, S ;
POWELL, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (08) :940-948